🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, I got to present the new EARL accreditation for brain PET harmonization in multi-center studies. I’m really happy that the harmonization method I worked on, which was validated in the AMYPAD study, is now being used by EARL and can help many colleagues. #AMYPAD #EANM2024

Join us at the CTAD for Poster 049 by Núria Tort-Colet: "Self-reported sleep quality and amyloid burden in cognitively unimpaired adults from the AMYPAD study" 🧠💤 📅Poster session 1: Tuesday, Oct 29, 3:00 pm to Wednesday, Oct 30, 5:00 pm Don't miss it! #CTAD24

📢 The Neuroimaging Research Group of BBRC, in collaboration with AMYPAD, has demonstrated the reliability of the #Centiloid metric for measuring amyloid plaques, one of the main hallmarks of Alzheimer’s. Mehrnaz مهرناز @DavidVallez Juando Gispert barcelonabeta.org/en/news/news/w…

The Neuroimaging Research Group of Barcelonaβeta Brain Research Center, in collaboration with AMYPAD, has demonstrated the reliability of the Centiloid metric as a reliable measure of AD-related amyloid plaques alzheimer-europe.org/news/amypad-re…

✨New Interview with Dr Emma Luckett, Postdoc Researcher & Data Manager at the Department of Radiology/Nuclear Medicine at the Amsterdam UMC. Don't miss this interview where she shares her AMYPAD work & what inspires her the most about research. amypad.eu/news/recent-ne…

At #CTAD24, Núria Tort-Colet from Barcelonaβeta Brain Research Center presented a poster investigating sleep quality and amyloid burden in AMYPAD participants, who show no signs of cognitive impairment. Learn more about this work here👇 amypad.eu/news/recent-ne…

Honored to have been awarded the Alzheimer Nederland Research Talent Award! 🤓 Extremely proud for my work to be recognized to have scientific and societal impact 🏥 Thanks to everyone who made this work possible 🙏 Frederik Barkhof AMYPAD Alzheimercentrum Amsterdam (inactief) RikOssenkoppele Oskar Hansson

🎉 Congratulations to Lyduine Collij on receiving the Alzheimer Nederland Research Talent Award, category post-doc 2-4 years after PhD!🏆 It's a well-deserved recognition of Lyduine's research and contributions to the field of Alzheimer's disease🙌 ➡️alzheimer-nederland.nl/nieuws/twee-de…

📢NEW AMYPAD paper out demonstrating the value of quantification to support visual assessment in a clinical study enriched for challenging amyloid PET cases. JNM Lyduine Collij @DavidVallez Valentina Garibotto Juando Gispert Frederik Barkhof 👏 jnm.snmjournals.org/content/early/…

Does amyloid-PET quantification really support visual assessment❓ Yes❗ In this latest AMYPAD paper, we show how the value of quant in challenging clinical cases 🧐 Check out the paper below 👇 Valentina Garibotto Silvia Morbelli Frederik Barkhof

🎯AMYPAD researchers have published context-of-use recommendations for the implementation of the Centiloid scale in clinical practice. Alzheimer's & Dementia Journals Innovative Health Initiative Lyduine Collij Mehrnaz مهرناز Frederik Barkhof @DavidVallez Juando Gispert To know more, visit⤵️ amypad.eu/news/recent-ne…

📢New paper out❗️We present the context-of-use of the robust and generalizable Centiloid scale in the clinical routine 🏥 and in the context of DMTs💊. What a timing after the amazing news from last Thursday on Lecanemab!🤓 Academia-EFPIA collaborations were key! AMYPAD

The AMYPAD Prognostic and Natural History Study has had a successful year💥 Visit our website to get an overview of the data accessibility, a snapshot of 2024, and a glimpse into the future with the #EuroPAD community ⤵️ amypad.eu/news/recent-ne…

Next up is Niklas Blomberg (Executive Director, Innovative Health Initiative) explaining how public-private partnerships advance dementia research Alzheimer Europe European Parliament #AELunchDebate AD-RIDDLE IHI Prominent PREDICTOM - IHI project AMYPAD SYNTHIA Mobilise-D European Platform for Neurodegenerative Diseases EBiSC

.AMYPAD has published Centiloid guidelines and recommendations for clinical context-of-use in #Alzheimer’s disease alzheimer-europe.org/news/amypad-pu…

La métrica centiloide es un #biomarcador eficaz para el diagnóstico y seguimiento de la enfermedad de #Alzheimer por su fiabilidad a la hora de medir las placas de #amiloide - geriatricarea.com/2024/12/13/la-… - GeriatricArea Fundación Pasqual Maragall AMYPAD

✨Wishing you a Happy New Year! 📢 The AMYPAD newsletter is out now! Get the latest updates, ongoing efforts, new papers and an interview with Dr Emma Luckett! Don't miss out, read it here ⤵️ mailchi.mp/f344d07d4657/a…

📢 Check out this recent opinion piece on the use of Centiloid threshold for anti-amyloid therapy published in The Journal of Prevention of Alzheimer's Disease. Many AMYPAD collaborators are acknowledged for sharing their input on the topic! ➡️sciencedirect.com/science/articl…

👉Check out this new paper assessing longitudinal brain atrophy and cognitive decline as a function of cerebrospinal fluid (CSF) AD biomarkers in the ALFA and EPAD cohorts! Congratulations to all authors 👏 Raffaele Cacciaglia alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…

We are now on #Bluesky🦋 Follow us there for updates, news and more! Even during the Innovative Health Initiative post-funding period, we’re continuing to make significant strides! We'd love to stay in touch - follow us⤵️ bsky.app/profile/imi-am…